| aCL | Anticardiolipin |
| ADMA | Asymmetric dimethyl arginine |
| Aix | Augmentation index |
| Akt | Phosphatidylinositol 3-kinase/protein kinase B |
| aPL | Antiphospholipid antibodies |
| ApoA1 | Apolipoprotein A1 |
| ApoB100 | Apolipoprotein B100 |
| APS | Anti-phospholipid syndrome |
| AUC | Area under the curve |
| B2GPI | Anti-beta-2-glycoprotein I |
| C3 | Complement 3 |
| C4 | Complement 4 |
| CH50 | 50% hemolytic complement |
| CVD | Cardiovascular disease |
| DMARDs | Disease-modifying anti-rheumatic drugs |
| dsDNA | Anti-double-stranded deoxyribonucleic acid |
| ELISA | Enzyme-linked immunosorbent assays |
| ET-1 | Endothelin-1 |
| FMD | Flow-mediated dilation |
| HDL-C | High-density lipoprotein cholesterol |
| hsCRP | High-sensitivity C-reactive protein |
| IDL | Intermediate density lipoprotein |
| IL-6 | Interleukine-6 |
| IMT | Common carotid intima-media thickness |
| LDL-C | Low-density lipoprotein cholesterol |
| LPL | Lipoprotein lipase |
| NO | Nitrogen-monoxide |
| NOS | Nitrogen-monoxide synthase |
| NSAIDs | Non-steroid anti-inflammatory drugs |
| PWV | Pulse-wave velocity |
| SLE | Systemic lupus erythematosus |
| SLEDAI | SLE Disease Activity Index |
| SLICC | Systemic Lupus International Collaborative Clinics |
| SSA | Anti-Sjögren’s-syndrome-related antigen A |
| SSB | Anti-Sjögren’s-syndrome-related antigen B |
| TG | Triglyceride |
| VLDL | Very low-density lipoprotein |